Upgrade to SI Premium - Free Trial

Mallinckrodt (MNK)

0.34 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- M&A (3/31/18 *Est)

Latest Headlines

Keenova Presents New TERLIVAZ® (terlipressin) Data Analyses at Kidney Week 2026 October 21, 2026 7:30 AM - PR NewsWire Keenova Presents a New TERLIVAZ® (terlipressin) Exploratory Analysis at American College of Gastroenterology Annual Meeting October 12, 2026 7:30 AM - PR NewsWire Keenova Announces New Presentations at the Sexual Medicine Society of North America Annual Meeting October 8, 2026 7:30 AM - PR NewsWire Keenova Marks the 2nd Annual National Hand Health Month with New Dupuytren's Contracture Mixed Reality Experience and Awareness Initiatives September 1, 2026 7:30 AM - PR NewsWire Keenova doses first patient in Phase 3 hammer toe drug trial August 20, 2026 7:30 AM - StreetInsider Keenova Advances Podiatry Pipeline with First Patient Dosed in Phase 3 Trial of XIAFLEX® (collagenase clostridium histolyticum) for Hammer Toe August 20, 2026 7:30 AM - PR NewsWire Keenova Reports Second Quarter 2026 Financial Results August 11, 2026 6:30 AM - PR NewsWire Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology August 3, 2026 7:30 AM - PR NewsWire Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026 July 30, 2026 7:00 AM - PR NewsWire Full Article List